IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates

ABSTRACT Antibodies acquired after vaccination or natural infection with Gram-negative bacteria, such as invasive Salmonella enterica serovar Typhimurium, can protect against disease. Immunization with naturally shed outer membrane vesicles from Gram-negative bacteria is being studied for its potent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna E. Schager, C. Coral Dominguez-Medina, Francesca Necchi, Francesca Micoli, Yun Shan Goh, Margaret Goodall, Adriana Flores-Langarica, Saeeda Bobat, Charlotte N. L. Cook, Melissa Arcuri, Arianna Marini, Lloyd D. W. King, Faye C. Morris, Graham Anderson, Kai-Michael Toellner, Ian R. Henderson, Constantino López-Macías, Calman A. MacLennan, Adam F. Cunningham
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/ae8cd71bd8374ad680c8e90aa28c510e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ae8cd71bd8374ad680c8e90aa28c510e
record_format dspace
spelling oai:doaj.org-article:ae8cd71bd8374ad680c8e90aa28c510e2021-11-15T15:53:26ZIgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates10.1128/mBio.02379-172150-7511https://doaj.org/article/ae8cd71bd8374ad680c8e90aa28c510e2018-05-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02379-17https://doaj.org/toc/2150-7511ABSTRACT Antibodies acquired after vaccination or natural infection with Gram-negative bacteria, such as invasive Salmonella enterica serovar Typhimurium, can protect against disease. Immunization with naturally shed outer membrane vesicles from Gram-negative bacteria is being studied for its potential to protect against many infections, since antigens within vesicles maintain their natural conformation and orientation. Shedding can be enhanced through genetic modification, and the resulting particles, generalized modules for membrane antigens (GMMA), not only offer potential as vaccines but also can facilitate the study of B-cell responses to bacterial antigens. Here we show that the response to immunization with GMMA from S. Typhimurium (STmGMMA) provides B-cell-dependent protection and induces antibodies to two immunodominant antigens, lipopolysaccharide (LPS) and porins. Antibodies to LPS O antigen (O-Ag) markedly enhance protection in the spleen, but this effect is less marked in the liver. Strikingly, IgG responses to LPS and porins develop with distinct kinetics. In the first week after immunization, there is a dramatic T-cell-independent B1b-cell-associated induction of all IgG isotypes, except IgG1, to porins but not to LPS. In contrast, production of IgG1 to either antigen was delayed and T cell dependent. Nevertheless, after 1 month, cells in the bone marrow secreting IgG against porins or LPS were present at a similar frequency. Unexpectedly, immunization with O-Ag-deficient STmGMMA did not substantially enhance the anti-porin response. Therefore, IgG switching to all antigens does not develop synchronously within the same complex and so the rate of IgG switching to a single component does not necessarily reflect its frequency within the antigenic complex. IMPORTANCE Vaccines save millions of lives, yet for some infections there are none. This includes some types of Salmonella infections, killing hundreds of thousands of people annually. We show how a new type of vaccine, called GMMA, that is made from blebs shed from the Salmonella cell wall, works to protect against infection in mice by inducing host proteins (antibodies) specifically recognizing bacterial components (antigens). The rate of development of IgG antibody to antigens within GMMA occurred with different kinetics. However, the antibody response to GMMA persists and is likely to provide prolonged protection for those who need it. These results help show how antibody responses to bacterial antigens develop and how vaccines like GMMA can work and help prevent infection.Anna E. SchagerC. Coral Dominguez-MedinaFrancesca NecchiFrancesca MicoliYun Shan GohMargaret GoodallAdriana Flores-LangaricaSaeeda BobatCharlotte N. L. CookMelissa ArcuriArianna MariniLloyd D. W. KingFaye C. MorrisGraham AndersonKai-Michael ToellnerIan R. HendersonConstantino López-MacíasCalman A. MacLennanAdam F. CunninghamAmerican Society for MicrobiologyarticleantibodiesB-cell responsesinfectionouter membrane vesiclesSalmonellavaccinesMicrobiologyQR1-502ENmBio, Vol 9, Iss 2 (2018)
institution DOAJ
collection DOAJ
language EN
topic antibodies
B-cell responses
infection
outer membrane vesicles
Salmonella
vaccines
Microbiology
QR1-502
spellingShingle antibodies
B-cell responses
infection
outer membrane vesicles
Salmonella
vaccines
Microbiology
QR1-502
Anna E. Schager
C. Coral Dominguez-Medina
Francesca Necchi
Francesca Micoli
Yun Shan Goh
Margaret Goodall
Adriana Flores-Langarica
Saeeda Bobat
Charlotte N. L. Cook
Melissa Arcuri
Arianna Marini
Lloyd D. W. King
Faye C. Morris
Graham Anderson
Kai-Michael Toellner
Ian R. Henderson
Constantino López-Macías
Calman A. MacLennan
Adam F. Cunningham
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
description ABSTRACT Antibodies acquired after vaccination or natural infection with Gram-negative bacteria, such as invasive Salmonella enterica serovar Typhimurium, can protect against disease. Immunization with naturally shed outer membrane vesicles from Gram-negative bacteria is being studied for its potential to protect against many infections, since antigens within vesicles maintain their natural conformation and orientation. Shedding can be enhanced through genetic modification, and the resulting particles, generalized modules for membrane antigens (GMMA), not only offer potential as vaccines but also can facilitate the study of B-cell responses to bacterial antigens. Here we show that the response to immunization with GMMA from S. Typhimurium (STmGMMA) provides B-cell-dependent protection and induces antibodies to two immunodominant antigens, lipopolysaccharide (LPS) and porins. Antibodies to LPS O antigen (O-Ag) markedly enhance protection in the spleen, but this effect is less marked in the liver. Strikingly, IgG responses to LPS and porins develop with distinct kinetics. In the first week after immunization, there is a dramatic T-cell-independent B1b-cell-associated induction of all IgG isotypes, except IgG1, to porins but not to LPS. In contrast, production of IgG1 to either antigen was delayed and T cell dependent. Nevertheless, after 1 month, cells in the bone marrow secreting IgG against porins or LPS were present at a similar frequency. Unexpectedly, immunization with O-Ag-deficient STmGMMA did not substantially enhance the anti-porin response. Therefore, IgG switching to all antigens does not develop synchronously within the same complex and so the rate of IgG switching to a single component does not necessarily reflect its frequency within the antigenic complex. IMPORTANCE Vaccines save millions of lives, yet for some infections there are none. This includes some types of Salmonella infections, killing hundreds of thousands of people annually. We show how a new type of vaccine, called GMMA, that is made from blebs shed from the Salmonella cell wall, works to protect against infection in mice by inducing host proteins (antibodies) specifically recognizing bacterial components (antigens). The rate of development of IgG antibody to antigens within GMMA occurred with different kinetics. However, the antibody response to GMMA persists and is likely to provide prolonged protection for those who need it. These results help show how antibody responses to bacterial antigens develop and how vaccines like GMMA can work and help prevent infection.
format article
author Anna E. Schager
C. Coral Dominguez-Medina
Francesca Necchi
Francesca Micoli
Yun Shan Goh
Margaret Goodall
Adriana Flores-Langarica
Saeeda Bobat
Charlotte N. L. Cook
Melissa Arcuri
Arianna Marini
Lloyd D. W. King
Faye C. Morris
Graham Anderson
Kai-Michael Toellner
Ian R. Henderson
Constantino López-Macías
Calman A. MacLennan
Adam F. Cunningham
author_facet Anna E. Schager
C. Coral Dominguez-Medina
Francesca Necchi
Francesca Micoli
Yun Shan Goh
Margaret Goodall
Adriana Flores-Langarica
Saeeda Bobat
Charlotte N. L. Cook
Melissa Arcuri
Arianna Marini
Lloyd D. W. King
Faye C. Morris
Graham Anderson
Kai-Michael Toellner
Ian R. Henderson
Constantino López-Macías
Calman A. MacLennan
Adam F. Cunningham
author_sort Anna E. Schager
title IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
title_short IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
title_full IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
title_fullStr IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
title_full_unstemmed IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <italic toggle="yes">Salmonella</italic> Develop at Discordant Rates
title_sort igg responses to porins and lipopolysaccharide within an outer membrane-based vaccine against nontyphoidal <italic toggle="yes">salmonella</italic> develop at discordant rates
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/ae8cd71bd8374ad680c8e90aa28c510e
work_keys_str_mv AT annaeschager iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT ccoraldominguezmedina iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT francescanecchi iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT francescamicoli iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT yunshangoh iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT margaretgoodall iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT adrianafloreslangarica iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT saeedabobat iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT charlottenlcook iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT melissaarcuri iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT ariannamarini iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT lloyddwking iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT fayecmorris iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT grahamanderson iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT kaimichaeltoellner iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT ianrhenderson iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT constantinolopezmacias iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT calmanamaclennan iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
AT adamfcunningham iggresponsestoporinsandlipopolysaccharidewithinanoutermembranebasedvaccineagainstnontyphoidalitalictoggleyessalmonellaitalicdevelopatdiscordantrates
_version_ 1718427295453020160